| Schedule of Earnings Per Share, Basic and Diluted |
The following table reconciles the numerators and denominators used in the computations of both basic and diluted (loss) income per share: | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions, except share data) | | Thirteen weeks ended September 27, 2026 | | Thirteen weeks ended September 28, 2025 | | Thirty-nine weeks ended September 27, 2026 | | Thirty-nine weeks ended September 28, 2025 | | Numerator: | | | | | | | | | | Net (loss) income attributable to common stockholders | | $ | (24.3) | | | $ | (14.7) | | | $ | (36.1) | | | $ | 3.3 | | | Denominator: | | | | | | | | | | Weighted average Class A Common Stock shares, basic | | 88,612,502 | | | 86,958,867 | | | 88,490,400 | | | 86,266,184 | | | Dilutive securities included in diluted earnings per share calculation: | | | | | | | | | | Warrants | | — | | | — | | | — | | | 821,898 | | | RSUs | | — | | | — | | | — | | | 453,147 | | | PSUs | | — | | | — | | | — | | | 253,455 | | | Stock options | | — | | | — | | | — | | | 322 | | | Total dilutive weighted average shares | | 88,612,502 | | | 86,958,867 | | | 88,490,400 | | | 87,795,006 | | | Basic (loss) income per share | | $ | (0.27) | | | $ | (0.17) | | | $ | (0.41) | | | $ | 0.04 | | | Diluted (loss) income per share | | $ | (0.27) | | | $ | (0.17) | | | $ | (0.41) | | | $ | 0.04 | | | Weighted average Class V Common Stock not subject to earnings per share calculation | | 55,349,000 | | | 55,349,000 | | | 55,349,000 | | | 55,451,564 | | | Net loss attributable to noncontrolling interest | | $ | (7.8) | | | $ | (5.5) | | | $ | (14.4) | | | $ | (7.7) | |
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The diluted earnings per share computation includes the effect of the 7,200,000 private placement warrants (the "Warrants") for the period in which they were outstanding. The Warrants were fully exercised in a cashless exchange in August 2025, resulting in the issuance of 1,307,873 shares of the Company's Class A Common Stock. The diluted earnings per share computation excludes the effect of certain RSUs, PSUs and stock options granted to directors and management that convert to Class A Common Stock upon vesting or being exercised, as their inclusion would have been anti-dilutive. Anti-dilutive securities excluded from diluted income per share calculations are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Thirteen weeks ended September 27, 2026 | | Thirteen weeks ended September 28, 2025 | | Thirty-nine weeks ended September 27, 2026 | | Thirty-nine weeks ended September 28, 2025 | | Warrants | | — | | | 405,578 | | | — | | | — | | | RSUs | | 1,659,862 | | | 626,373 | | | 1,566,640 | | | 113,567 | | | PSUs | | 803,099 | | | 541,926 | | | 826,360 | | | 436,990 | | | Stock options | | 649,930 | | | 633,179 | | | 649,930 | | | 633,007 | |
|